JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M414356200 on March 24, 2005

J. Biol. Chem., Vol. 280, Issue 21, 20365-20374, May 27, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/21/20365    most recent
M414356200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shang, F.
Right arrow Articles by Taylor, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shang, F.
Right arrow Articles by Taylor, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Lys6-modified Ubiquitin Inhibits Ubiquitin-dependent Protein Degradation*

Fu Shang{ddagger}§, Gejing Deng{ddagger}, Qing Liu{ddagger}, Weimin Guo{ddagger}, Arthur L. Haas¶, Bernat Crosas||, Daniel Finley||, and Allen Taylor{ddagger}

From the {ddagger}Laboratory for Nutrition and Vision Research, Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111, the Department of Biochemistry and Molecular Biology, Louisiana State University School of Medicine, New Orleans, Louisiana 70112, and the ||Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02138

Ubiquitin plays essential roles in various cellular processes; therefore, it is of keen interest to study the structure-function relationship of ubiquitin itself. We investigated the modification of Lys6 of ubiquitin and its physiological consequences. Mass spectrometry-based peptide mapping and N-terminal sequencing demonstrated that, of the 7 Lys residues in ubiquitin, Lys6 was the most readily labeled with sulfosuccinimidobiotin. Lys6-biotinylated ubiquitin was incorporated into high molecular mass ubiquitin conjugates as efficiently as unmodified ubiquitin. However, Lys6-biotinylated ubiquitin inhibited ubiquitin-dependent proteolysis, as conjugates formed with Lys6-biotinylated ubiquitin were resistant to proteasomal degradation. Ubiquitins with a mutation of Lys6 had similar phenotypes as Lys6-biotinylated ubiquitin. Lys6 mutant ubiquitins (K6A, K6R, and K6W) also inhibited ATP-dependent proteolysis and caused accumulation of ubiquitin conjugates. Conjugates formed with K6W mutant ubiquitin were also resistant to proteasomal degradation. The dominant-negative effect of Lys6-modified ubiquitin was further demonstrated in intact cells. Overexpression of K6W mutant ubiquitin resulted in accumulation of intracellular ubiquitin conjugates, stabilization of typical substrates for ubiquitin-dependent proteolysis, and enhanced susceptibility to oxidative stress. Taken together, these results show that Lys6-modified ubiquitin is a potent and specific inhibitor of ubiquitin-mediated protein degradation.


Received for publication, December 21, 2004 , and in revised form, March 21, 2005.

* This work was supported in part by National Institutes of Health Grants EY11717 (to F. S.), EY13250 (to A. T.), and GM34009 (to A. L. H.) and by the United States Department of Agriculture under Agreement 58-1950-9-001. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Lab. for Nutrition and Vision Research, Jean Mayer USDA HNRCA, Tufts University, 711 Washington St., Boston, MA 02111. Tel.: 617-556-3158; Fax: 617-556-3344; E-mail: fu.shang{at}tufts.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
X. Zhang, J. Zhou, A. F. Fernandes, J. R. Sparrow, P. Pereira, A. Taylor, and F. Shang
The Proteasome: A Target of Oxidative Damage in Cultured Human Retina Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3622 - 3630.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. F. Fernandes, J. Zhou, X. Zhang, Q. Bian, J. Sparrow, A. Taylor, P. Pereira, and F. Shang
Oxidative Inactivation of the Proteasome in Retinal Pigment Epithelial Cells: A POTENTIAL LINK BETWEEN OXIDATIVE STRESS AND UP-REGULATION OF INTERLEUKIN-8
J. Biol. Chem., July 25, 2008; 283(30): 20745 - 20753.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Zhang, E. J. Dudek, B. Liu, L. Ding, A. F. Fernandes, J. J. Liang, J. Horwitz, A. Taylor, and F. Shang
Degradation of C-terminal Truncated {alpha}A-crystallins by the Ubiquitin Proteasome Pathway
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4200 - 4208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Cripps, S. N. Thomas, Y. Jeng, F. Yang, P. Davies, and A. J. Yang
Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation
J. Biol. Chem., April 21, 2006; 281(16): 10825 - 10838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.